ResMed (RMD) shares were down about 4% in Wednesday trading after Morgan Stanley downgraded the stock to equal weight from overweight and cut its price target to $230 from $286.
Trading volume stood at more than 1.0 million shares, compared with a daily average of about 1.3 million.
Price: 186.15, Change: -7.79, Percent Change: -4.02